MITA again urges medical device exemption in China tariffs

With the U.S.-China tariffs now underway, the Medical Imaging and Technology Alliance (MITA) has again appealed to the Trump administration to make an exemption for medical imaging devices.

The Section 301 tariffs on goods manufactured in China may harm the U.S. medical technology industry's capacity to remain competitive and, ultimately, compromise patient access to healthcare services, MITA Executive Director Patrick Hope said in a statement. The tariffs could cost the industry billions of dollars, including more than $138 million this year.

Although the administration has said it will implement an exemption process for medical devices, it has yet to provide any information about how or when it will do so, Hope said.